Skip to main content
TipRanks
Go Ultimate75% OFF

Ingredion (CNP) AI Stock Analysis

0 Followers
CH:CNP

Ingredion

(BX Swiss:CNP)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Specialty ingredient growthSustained volume growth in Texture & Healthful Solutions and Clean Label products indicates durable customer demand for differentiated functionality, nutrition, and simpler formulations. This specialty mix can support stronger customer retention and more resilient margins than commodity-oriented ingredients over the coming quarters.
Negative Factors
Declining earnings trajectoryRecent revenue contraction and margin giveback point to a less consistent earnings trajectory, increasing the risk that weaker demand and mix pressure persist beyond a single quarter. Lower operating profitability can reduce funds available for growth investments and make shareholder returns more dependent on cash-flow stability.

Ingredion Business Overview & Revenue Model

Company Description

Ingredion Incorporated, along with its affiliated entities, specializes in the global production and sale of starches and sweeteners, catering to a diverse range of industries. The company's operations are strategically organized into four geographic...

Ingredion Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentNegative

The call had some meaningful operational and strategic positives, including continued Texture & Healthful Solutions volume growth, strong Clean Label momentum, LATAM volume growth, Argo production stabilization, progress on the Tate & Lyle transaction, and ongoing shareholder returns. However, these positives were outweighed by a 19% decline in adjusted operating income, lower adjusted EPS, persistent Argo cost and yield issues, record tapioca costs, weaker U.S./Canada demand, currency and earthquake impacts, declining cash flow, and a reduced full-year outlook.

Positive Updates

Texture & Healthful Solutions Delivered Tenth Consecutive Quarter of Volume Growth
Texture & Healthful Solutions net sales volume increased 2%, marking the 10th consecutive quarter of volume growth. Clean Label Solutions sales were up 8% year to date, with growth in every region; Asia Pacific grew more than 30%, and U.S./Canada delivered its highest revenue quarter in the last two years.

Negative Updates

Third-Quarter Profitability Fell Short of Expectations
Management said third-quarter results fell short of expectations. Net sales were $1.8 billion, down 1% year over year, or up 2% excluding the Pakistan divestiture. Adjusted operating income was $206 million, down 19%, primarily due to higher manufacturing costs, lower Food & Industrial Ingredients U.S./Canada volumes, higher tapioca costs, and the stronger Mexican peso.

Company Guidance

For the full year 2026, Ingredion anticipates net sales to be flat, adjusted operating income to be down mid-teens, and adjusted EPS to be in the range of $9.25-$9.70, assuming diluted shares outstanding of 63.5 million to 64 million, including completion of the planned $100 million of share repurchases; cash from operations is expected to be in the range of $650 million-$750 million and capital expenditures between $450 million-$490 million. By segment, Texture & Healthful Solutions net sales are expected to be up low single digits and operating income flat to up low single digits; Food & Industrial Ingredients LATAM net sales up low to mid-single digits and operating income down mid to high single digits; Food & Industrial Ingredients U.S./Canada net sales down mid-single digits and operating income down 35%-40%; and All other net sales down 20%-25%, with an operating loss approximately $15 million. Guidance reflects current tariff levels in effect at the end of October 2026 and excludes any acquisition-related integration and restructuring costs, as well as any potential impairment costs; the Tate & Lyle transaction remains targeted to close in the second half of 2027.

Ingredion Risk Analysis

Ingredion disclosed 35 risk factors in its most recent earnings report. Ingredion reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The market price of our common stock after the pending acquisition may be affected by factors different from those affecting the market price of our common stock before the pending acquisition.Q2, 2026
2.The market price of our common stock may decline as a result of the pending acquisition.Q2, 2026
3.The combined group will have significantly more indebtedness than our indebtedness before the pending acquisition.Q2, 2026

Ingredion Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

CH:CNP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
MKCMKC77Outperform$12.64B8.4622.32%4.09%13.23%91.32%
DARDAR76Outperform$8.67B10.4616.72%―15.79%687.52%
MZTIMZTI74Outperform$3.02B17.4816.83%3.60%-0.94%2.86%
JJSFJJSF68Neutral$1.65B33.815.40%3.62%-4.69%-39.51%
JBSSJBSS63Neutral$690.62M12.2814.95%7.62%3.13%-14.89%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%

* Consumer Defensive Sector Average

Performance Comparison

0%50%DARJJSFJBSSMZTIMKCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:CNP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DARDarling Ingredients55.9921.5662.62%
JJSFJ & J Snack Foods88.397.519.28%
JBSSJohn B. Sanfilippo & Son59.06-5.32-8.26%
MZTIMarzetti Company110.97-51.94-31.88%
MKCMcCormick & Company Inc46.96-15.36-24.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.